Targovax is invited to present at Solebury Trout European Biotech Investor Day in NYC

Oslo, Norway, 31 July 2019 – Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that the Company is invited to present at the Solebury Trout European Biotech Investor Day 2019 in NYC.

Date: 1 August 2019
Time: 10:30 AM EDT
Presenter: Øystein Soug (CEO)

The presentation will be available to download at www.targovax.com after the event.

For further information, please contact:
Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Email: renate.birkeli@targovax.com

Media and IR enquires:
Andreas Tinglum – Corporate Communications (Norway)
Phone: +47 9300 1773
Email: andreas.tinglum@corpcom.no